Cryptosporidiosis should be designated as a tropical disease by the US Food and Drug Administration

Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis

(2019) Beatriz Baragaña et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Development of 5-Aminopyrazole-4-carboxamide-based Bumped-Kinase Inhibitors for Cryptosporidiosis Therapy

(2019) Wenlin Huang et al.   JOURNAL OF MEDICINAL CHEMISTRY

Piperazine-Derivative MMV665917: an effective drug in the diarrheic piglet model of Cryptosporidium hominis

(2019) Sangun Lee et al.   JOURNAL OF INFECTIOUS DISEASES

Optimization of Methionyl tRNA-Synthetase Inhibitors for Treatment of Cryptosporidium Infection

(2019) Frederick S. Buckner et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis

(2019) Christopher S. Lunde et al.   Nature Communications

Cryptosporidiosis Outbreaks — United States, 2009–2017

(2019) Radhika Gharpure et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Metal-captured inhibition of pre-mRNA processing activity by CPSF3 controls Cryptosporidium infection

(2019) Christopher Swale et al.   Science Translational Medicine

Diarrhoeal disease and subsequent risk of death in infants and children residing in low-income and middle-income countries: analysis of the GEMS case-control study and 12-month GEMS-1A follow-on study

(2019) Myron M Levine et al.   Lancet Global Health

A Novel Piperazine-Based Drug Lead for Cryptosporidiosis from the Medicines for Malaria Venture Open-Access Malaria Box

(2018) R. S. Jumani et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical and microbiologic efficacy of the piperazine-based drug lead MMV665917 in the dairy calf cryptosporidiosis model

(2018) Erin Stebbins et al.   PLoS Neglected Tropical Diseases

Morbidity, mortality, and long-term consequences associated with diarrhoea from Cryptosporidium infection in children younger than 5 years: a meta-analyses study

(2018) Ibrahim A Khalil et al.   Lancet Global Health

Outbreaks Associated with Treated Recreational Water — United States, 2000–2014

(2018) Michele C. Hlavsa et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Evaluating the safety, tolerability, pharmacokinetics and efficacy of clofazimine in cryptosporidiosis (CRYPTOFAZ): study protocol for a randomized controlled trial

(2018) Patrick Nachipo et al.   Trials

The trypanocidal benzoxaborole AN7973 inhibits trypanosome mRNA processing

(2018) Daniela Begolo et al.   PLoS Pathogens

Creative use of the priority review voucher by public and not-for-profit actors delivers the first new FDA-approved treatment for river blindness in 20 years

(2018) Piero L. Olliaro et al.   PLoS Neglected Tropical Diseases

Advances in bumped kinase inhibitors for human and animal therapy for cryptosporidiosis

(2017) Matthew A. Hulverson et al.   INTERNATIONAL JOURNAL FOR PARASITOLOGY

A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis

(2017) Ujjini H. Manjunatha et al.   NATURE

A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis

(2017) Melissa S. Love et al.   PLoS Neglected Tropical Diseases

Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study

(2016) Jie Liu et al.   LANCET

The Burden of Cryptosporidium Diarrheal Disease among Children < 24 Months of Age in Moderate/High Mortality Regions of Sub-Saharan Africa and South Asia, Utilizing Data from the Global Enteric Multicenter Study (GEMS)

(2016) Samba O. Sow et al.   PLoS Neglected Tropical Diseases

Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED)

(2015) James A Platts-Mills et al.   Lancet Global Health

Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study

(2013) Karen L Kotloff et al.   LANCET